Clinical trials recruiting for Stage IIIC Non-Small Cell Lung Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin (AUC 5) | 1 |
| Paclitaxel | 1 |
| Pemetrexed 500 mg/m2 | 1 |
| Sintilimab | 1 |
| Stereotactic body radiotherapy (SBRT) | 1 |
Self-screener
Recruiting trials
- Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
- Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
Related conditions
Trials recruiting for Stage IIIC Non-Small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Stage IV Non-small Cell Lung Cancer 7Non-small cell lung cancer 507Locally Advanced Non-Small Cell Lung Cancer 11
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage IIIC Non-Small Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.